FDA label 437c55fa-8a65-193c-e054-00144ff88e88

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

SPL set ID
f20176fb-205c-4368-b510-cbd296cb8152
SPL ID
437c55fa-8a65-193c-e054-00144ff88e88
Version
2
Effective date
2016-12-12
Source export date
2026-08-17
Source partition
1
Source file
https://download.open.fda.gov/drug/label/drug-label-0001-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-08-17/559e90e291f706011ac4a15e81427bf26ca36e5d0b9d84e84d297d7c5834404b/drug-label-0001-of-0014.json.zip
Source manifest SHA-256
ca19d5b1416b6b66a9d383bfdc77d90e91adfeefe16ffcc1ac6b06ceb90d8d73
Import run
20260818T065550Z
Imported at
2026-08-18 07:01:01

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 2 matching rows.

warnings

WARNINGS Furosemide USP is a potent diuretic which, if given in excessive amounts, can lead to a profound diuresis with water and electrolyte depletion. Therefore, careful medical supervision is required and dose and dose schedule must be adjusted to the individual patient’s needs (see DOSAGE AND ADMINISTRATION ).

warnings

WARNINGS In patients with hepatic cirrhosis and ascites, furosemide therapy is best initiated in the hospital. In hepatic coma and in states of electrolyte depletion, therapy should not be instituted until the basic condition is improved. Sudden alterations of fluid and electrolyte balance in patients with cirrhosis may precipitate hepatic coma; therefore, strict observation is necessary during the period of diuresis. Supplemental potassium chloride and, if required, an aldosterone antagonist are helpful in preventing hypokalemia and metabolic alkalosis. If increasing azotemia and oliguria occur during treatment of severe progressive renal disease, furosemide should be discontinued. Cases of tinnitus and reversible or irreversible hearing impairment and deafness have been reported. Reports usually indicate that furosemide ototoxicity is associated with rapid injection, severe renal impairment, the use of higher than recommended doses, hypoproteinemia or concomitant therapy with aminoglycoside antibiotics, ethacrynic acid, or other ototoxic drugs. If the physician elects to use high dose parenteral therapy, controlled intravenous infusion is advisable (for adults, an infusion rate not exceeding 4 mg furosemide per minute has been used) (see PRECAUTIONS, Drug Interactions ).

Adverse reactions cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Adverse reactions sections page 1 of 1 · 2 matching rows.

adverse reactions

ADVERSE REACTIONS Adverse reactions are categorized below by organ system and listed by decreasing severity. Gastrointestinal System Reactions 1. hepatic encephalopathy in patients with hepatocellular insufficiency 6. oral and gastric irritation 2. pancreatitis 7. cramping 3. jaundice (intrahepatic cholestatic jaundice) 8. diarrhea 4. increased liver enzymes 9. constipation 5. anorexia 10. nausea 11. vomiting Systemic Hypersensitivity Reactions 1. Severe anaphylactic or anaphylactoid reactions (e.g., with shock) 3. interstitial nephritis 2. systemic vasculitis 4. necrotizing angiitis Central Nervous System Reactions 1. tinnitus and hearing loss 4. dizziness 2. paresthesias 5. headache 3. vertigo 6. blurred vision 7. xanthopsia Hematologic Reactions 1. aplastic anemia 2. thrombocytopenia 5. leukopenia 3. agranulocytosis 6. anemia 4. hemolytic anemia 7. eosinophilia Dermatologic - Hypersensitivity Reactions 1. toxic epidermal necrolysis 7. bullous pemphigoid 2. Stevens-Johnson Syndrome 8. purpura 3. erythema multiforme 9. photosensitivity 4.drug rash with eosinophilia and systemic symptoms 10. rash 5. acute generalized exanthematous pustulosis 11. pruritis 6. exfoliative dermatitis 12. urticaria Cardiovascular Reaction 1. Orthostatic hypotension may occur and be aggravated by alcohol, barbiturates or narcotics. 2. Increase in cholesterol and triglyceride serum levels. Other Reactions 1. hyperglycemia 6. restlessness 2. glycosuria 7. urinary bladder spasm 3. hyperuricemia 8. thrombophlebitis 4. muscle spasm 9. fever 5. weakness Whenever adverse reactions are moderate or severe, furosemide dosage should be reduced or therapy withdrawn.

adverse reactions table

<table ID="id_98eb2e45-96d0-46c8-a95b-398ce5f9ffc8" border="single" width="468.000"> <col span="1" width="53.2%"/> <col span="1" width="46.8%"/> <tbody> <tr> <td> <content styleCode="bold">Gastrointestinal System Reactions </content> </td> </tr> <tr> <td> <paragraph> 1. hepatic encephalopathy in patients with</paragraph> hepatocellular insufficiency </td> <td> 6. oral and gastric irritation</td> </tr> <tr> <td> 2. pancreatitis </td> <td> 7. cramping</td> </tr> <tr> <td> 3. jaundice (intrahepatic cholestatic jaundice) </td> <td> 8. diarrhea</td> </tr> <tr> <td> 4. increased liver enzymes</td> <td> 9. constipation</td> </tr> <tr> <td> 5. anorexia </td> <td>10. nausea</td> </tr> <tr> <td/> <td>11. vomiting</td> </tr> <tr> <td> </td> <td> </td> </tr> <tr> <td> <content styleCode="bold">Systemic Hypersensitivity Reactions</content> </td> </tr> <tr> <td> 1. Severe anaphylactic or anaphylactoid reactions (e.g., with shock)</td> <td> 3. interstitial nephritis </td> </tr> <tr> <td> 2. systemic vasculitis </td> <td> 4. necrotizing angiitis</td> </tr> <tr> <td> </td> <td> </td> </tr> <tr> <td> <content styleCode="bold">Central Nervous System Reactions</content> </td> </tr> <tr> <td> 1. tinnitus and hearing loss </td> <td> 4. dizziness </td> </tr> <tr> <td> 2. paresthesias </td> <td> 5. headache </td> </tr> <tr> <td> 3. vertigo </td> <td> 6. blurred vision </td> </tr> <tr> <td> </td> <td> 7. xanthopsia </td> </tr> <tr> <td> </td> <td> </td> </tr> <tr> <td> <content styleCode="bold">Hematologic Reactions</content> </td> </tr> <tr> <td> 1. aplastic anemia </td> <td/> </tr> <tr> <td> 2. thrombocytopenia </td> <td> 5. leukopenia </td> </tr> <tr> <td> 3. agranulocytosis</td> <td> 6. anemia </td> </tr> <tr> <td> 4. hemolytic anemia</td> <td> 7. eosinophilia </td> </tr> <tr> <td/> <td/> </tr> <tr> <td> <content styleCode="bold">Dermatologic - Hypersensitivity Reactions</content> </td> <td> </td> </tr> <tr> <td> 1. toxic epidermal necrolysis</td> <td> 7. bullous pemphigoid </td> </tr> <tr> <td> 2. Stevens-Johnson Syndrome </td> <td> 8. purpura</td> </tr> <tr> <td> 3. erythema multiforme </td> <td> 9. photosensitivity</td> </tr> <tr> <td> 4.drug rash with eosinophilia and systemic symptoms</td> <td> 10. rash</td> </tr> <tr> <td> 5. acute generalized exanthematous pustulosis</td> <td> 11. pruritis</td> </tr> <tr> <td> 6. exfoliative dermatitis </td> <td> 12. urticaria</td> </tr> <tr> <td/> <td/> </tr> <tr> <td> <content styleCode="bold">Cardiovascular Reaction</content> </td> </tr> <tr> <td> <paragraph>1. Orthostatic hypotension may occur and be aggravated by alcohol, barbiturates or narcotics.</paragraph>2. Increase in cholesterol and triglyceride serum levels. </td> </tr> <tr> <td/> </tr> <tr> <td> <content styleCode="bold">Other Reactions</content> </td> </tr> <tr> <td> 1. hyperglycemia </td> <td> 6. restlessness </td> </tr> <tr> <td> 2. glycosuria </td> <td> 7. urinary bladder spasm </td> </tr> <tr> <td> 3. hyperuricemia </td> <td> 8. thrombophlebitis </td> </tr> <tr> <td> 4. muscle spasm </td> <td> 9. fever </td> </tr> <tr> <td> 5. weakness </td> <td> </td> </tr> </tbody> </table>